Information for US Customers: Our dedicated website, sudoscan.us, is currently unavailable. For assistance, please feel free to contact us via email at admin@sudoscan.com or by phone at +18584502800.
SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.
Small fiber neuropathies have been assessed using SUDOSCAN in different diseases and therapeutic areas.
SUDOSCAN has demonstrated its clinical utility to detect chemotherapy induced polyneuropathy (CIPN).
SUDOSCAN has demonstrated its clinical utility in Nephrology.
A key clinical application of SUDOSCAN is longitudinal follow-up and patient management.
Events / News
SUCCESSFUL WEB CONFERENCE ON SUDOSCAN UTILITY IN DIABETES On July [...]
Diabetes / Events / News / Scientific publications
EASD 2019 POSTER:DIABETIC FOOT RISK DETECTION A multi-center study (3 [...]
Events
SUDOSCAN IN DIABETES: IDENTIFICATION AND FOLLOW-UP OF THE AT RISK [...]
SUDOSCAN at JNLF 2019. Meet us on booth n°13 from april 16th to 19th 2019.
Δ
April 20, 2025